Manufacturing

The new European Biotech and Biomanufacturing Hub

The new Biotech and Biomanufacturing Hub, a key milestone in the European Commission's Strategy to boost biotechnology and biomanufacturing in the EU, was officially launched on 30 January 2025. Designed as a central reference point, the Hub is accessible through the Your Europe web portal and aims to streamline the scale-up process while making it easier for businesses to navigate complex regulatory frameworks

Capillary electrophoresis: theory and pharmaceutical applications

Electrophoresis is an analytical technique used in the separation of charged species by means of an electric field. Electrostatic attraction pushes positively charged ions toward the negative electrode (cathode) and negatively charged ions toward the positive electrode (anode)

R&D

The Warsaw Declaration on the future of framework programmes

The Warsaw Declaration, released during the informal meeting of research ministers held on 10 and 11 March 2025 under the Polish presidency of the Council, contains the recommendations for the negotiations of the post-2027 Multiannual Financial Framework

EuropaBio’s position on how to support ATMPs development

Advanced Therapy Medicinal Products (ATMPs) have represented the new paradigm in healthcare since the beginning of the new millennium. A position paper by EuropaBio summarised the recommendation of the industrial representative to support the role of ATMPs as a key driver of health innovation

Newsstand

  • Supplemento to n.9 - October 2024 NCF International n.3 - 2024
  • NCF International n.2 - 2024
  • Supplemento to n.1 - January 2024 NCF International n.1 - 2024